REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Chongqing Genrix Biopharmaceutical Co., Ltd. Profile Updated: November 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Chongqing Genrix Biopharmaceutical Co.,ltd. is engaged in the research and development, production and sales of antibody drugs. The company's research products are monoclonal antibody drugs and bispecific antibody drugs. The company was established in 2015 and is headquartered in Chongqing City, China.

Headquarters
No. 699, Maliu Avenue, Banan District, Chongqing
Chongqing; Chongqing; Postal Code: 401338

Contact Details: Purchase the Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司) report to view the information.

Website: http://www.genrixbio.com

Basic Information
Total Employees:
Purchase the Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司) report to view the information.
Registered Capital:
Purchase the Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司) report to view the information.
Financial Auditors:
Purchase the Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司) report to view the information.
Incorporation Date:
October 20, 2015
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
54.54%
Purchase this report to view the information.
3.97%
Purchase this report to view the information.
3.13%
Purchase this report to view the information.
2.45%
Purchase this report to view the information.
1.7%
Subsidiaries
Beijing Zhirenmeibo Biotechnology Co., Ltd.
100%
Zhixiang (Shanghai) Pharmaceutical Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
1562.05%▲
Total operating revenue
1496.02%▲
Operating profit (EBIT)
40.29%▲
Net Profit (Loss) for the Period
39.12%▲
Total assets
-7.18%▼
Total equity
-24.03%▼
Operating Profit Margin (ROS)
4213.68%▲
Net Profit Margin
4214.75%▲
Return on Equity (ROE)
4.62%▲
Debt to Equity Ratio
18.18%▲
Quick Ratio
-11.25%▼
Cash Ratio
-10.63%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
JD Health International Inc.
Nanjing Pharmaceutical Company Limited
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Jiangsu Recbio Technology Company Limited
 
Transcenta Holding Limited (Hong Kong) (创胜集团医药有限公司 (香港))
Shouyao Holdings Co.,Ltd (首药控股(北京)股份有限公司)
 
Tyk Medicines Inc.
Suntar Eco-City Limited
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo